This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Merz Pharma Gmbh & Co. Kgaa. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Gudrun Klein - Innovator in Botulinum Toxin Treatments
Introduction
Gudrun Klein is an accomplished inventor based in Frankfurt-am-Main, Germany. She is currently associated with Merz Pharma GmbH & Co. KGaA, where she focuses on innovative treatments in the field of aesthetics. Although she has not yet been granted any patents, her contributions to the field are noteworthy.
Latest Patent Applications
One of her significant patent applications is titled "High Dose and Low Volume Botulinum Toxin Treatment of Facial Wrinkles." This invention relates to the use of botulinum toxin for treating facial wrinkles, where the toxin is administered at high doses, ranging from 50 U to 200 U, using small injection volumes of 0.05 ml to 0.35 ml. The application outlines a method for treating facial wrinkles, such as glabellar frown lines, by injecting small volumes of a highly concentrated botulinum toxin solution into targeted facial areas.
Conclusion
Gudrun Klein's work in the field of botulinum toxin treatments showcases her innovative spirit and dedication to advancing aesthetic medicine. Her ongoing research and applications hold promise for future developments in this area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile